ITGAM and glioma: Transcriptome profiling of bulk CD11b+ cells isolated from human glioblastomas (GBMs) and rodent gliomas showed a mixture of protumorigenic and antitumorigenic phenotypes, and did not reveal consistent markers and pathways4–6.